A detailed history of Vanguard Group Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,038,126 shares of MRVI stock, worth $71.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,038,126
Previous 10,003,894 0.34%
Holding current value
$71.9 Million
Previous $65.5 Million 32.82%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$5.11 - $8.76 $174,925 - $299,872
34,232 Added 0.34%
10,038,126 $87 Million
Q4 2023

Feb 14, 2024

SELL
$4.7 - $9.87 $1 Million - $2.11 Million
-213,388 Reduced 2.09%
10,003,894 $65.5 Million
Q3 2023

Nov 14, 2023

SELL
$9.14 - $12.85 $3.12 Million - $4.39 Million
-341,685 Reduced 3.24%
10,217,282 $102 Million
Q2 2023

Aug 14, 2023

SELL
$12.09 - $15.0 $2,780 - $3,450
-230 Reduced -0.0%
10,558,967 $131 Million
Q1 2023

May 15, 2023

BUY
$12.99 - $16.48 $2.2 Million - $2.79 Million
169,218 Added 1.63%
10,559,197 $148 Million
Q4 2022

Feb 10, 2023

BUY
$12.5 - $24.78 $2.22 Million - $4.4 Million
177,381 Added 1.74%
10,389,979 $149 Million
Q3 2022

Nov 14, 2022

SELL
$20.6 - $30.37 $4.54 Million - $6.69 Million
-220,435 Reduced 2.11%
10,212,598 $261 Million
Q2 2022

Aug 12, 2022

SELL
$26.05 - $37.48 $2.06 Million - $2.97 Million
-79,184 Reduced 0.75%
10,433,033 $296 Million
Q1 2022

May 13, 2022

SELL
$24.46 - $40.92 $523,248 - $875,360
-21,392 Reduced 0.2%
10,512,217 $371 Million
Q4 2021

Feb 14, 2022

BUY
$35.0 - $45.94 $14.9 Million - $19.6 Million
426,670 Added 4.22%
10,533,609 $441 Million
Q3 2021

Nov 12, 2021

BUY
$36.8 - $60.62 $64.7 Million - $107 Million
1,758,189 Added 21.06%
10,106,939 $496 Million
Q2 2021

Aug 13, 2021

BUY
$32.46 - $45.0 $271 Million - $376 Million
8,348,750 New
8,348,750 $348 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $942M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.